CSF cytology versus immunocytochemistry in meningeal carcinomatosis

52Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

CSF immunocytochemistry with monoclonal antibodies was compared with conventional cytology to determine its sensitivity in detecting malignant cells in patients with meningeal carcinomatosis. One hundred and eighteen samples were investigated. Cytology was tumour positive in 83 samples and immunocytochemistry in 85. Dissimilar results between the two diagnostic methods were noted in 12 specimens, invariably occurring in samples with a low cell count and obtained from treated patients. Combined use of the two methods led to a 9% increase of sensitivity in detecting malignant cells compared with cytology alone. It is concluded that immunocytochemistry is of minor help in the problem of false-negative cytology in meningeal carcinomatosis.

Cite

CITATION STYLE

APA

Boogerd, W., Vroom TH., M., Van Heerde, P., Brutel de la Riviere, G., Peterse, J. L., & Van der Sande, J. J. (1988). CSF cytology versus immunocytochemistry in meningeal carcinomatosis. Journal of Neurology Neurosurgery and Psychiatry, 51(1), 142–145. https://doi.org/10.1136/jnnp.51.1.142

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free